{"id":"84acaaff-bc66-4dc6-a1ea-e2a1dcfb4f7f","kind":"institutions","code":"UB-I7363","name":"Alderline Group","nameBasis":"original-brand","summary":"Alderline Group, an investment holding organization.","description":"Alderline Group, an investment holding organization.","country":null,"category":null,"originalName":"Alderline Group","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:13.731Z","englishUpdatedAt":"2026-10-16T01:39:37.810Z","reviewedAt":"2026-10-16T01:39:37.810Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"790a7340acc1168b381e7deeafdbefbfdb0c4a99fa9fbb8d2962d385669c9df5","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"Alderline Group，投资控股机构。","sources":[],"related":[{"id":"f138535b-b046-46b6-b65d-9519a7ba8390","kind":"news","code":"f138535b-b046-46b6-b65d-9519a7ba8390","name":"Enveda Biosciences raises USD 311 million in Series E financing","nameBasis":"translated-title","summary":"On 2026-09-24, according to Xiniu Data, Enveda Biosciences completed Series E financing, raising USD 311 million. Investors were lead investor Catalio Capital Management, Durable Capital Partners, ICONIQ, Lightspeed and others. The company is a developer of AI natural product drugs.","description":"","country":null,"category":null,"originalName":"Enveda Biosciences完成E轮融资，融资金额3.11亿美元","eventDate":"2026-09-24T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T13:58:30.970Z","englishUpdatedAt":"2026-10-15T21:56:38.837Z","reviewedAt":"2026-10-15T21:56:38.837Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"ef26800a86f832f09c886a3577e0372be2ba8049f66d9caff7fb8c8e16eb08e6","companyId":"709f4fb9-903d-4d79-b9c2-4f4c1f6f535b","foundedYear":null,"logoUrl":null,"path":"/news/f138535b-b046-46b6-b65d-9519a7ba8390"}],"path":"/institutions/alderline-group","canonical":"https://uniquebase.ai/institutions/alderline-group"}